The downregulation of miR-125a and miR-125b was also observed in ovarian cancer patients (Figure 1A, 1B), accompanied by a significant increase in EIF4EBP1 mRNA expression (Figure 1C). This evidence concerns the gene EIF4EBP1 and ovarian carcinoma.